Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive neoplasm with a poor outcome. Novel L-asparaginase-based treatment regimens, such as GELOX (gemcitabine, oxaliplatin, and L-asparaginase) and P-gemox (gemcitabine, oxaliplatin, and pegaspargase), have shown promising results against...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing-hua, Wang, Hua, Wang, Yan-jun, Xia, Zhong-jun, Huang, Hui-qiang, Jiang, Wen-qi, Lu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085239/
https://www.ncbi.nlm.nih.gov/pubmed/27072578
http://dx.doi.org/10.18632/oncotarget.8643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085239/
https://www.ncbi.nlm.nih.gov/pubmed/27072578
http://dx.doi.org/10.18632/oncotarget.8643

Ejemplares similares